Title : Genetic engineering of VHH-with-multiple-paratopes (Single domain with multidomain antibody megabody) Targeting Multiple (TM) cytokines in the osteoarthtis joints as a potential of DMOAD
Abstract:
VHH is a single-domain antibody that can bind to the epitope(s) of its target antigen(s) in a very efficient way due to its tiny size. Osteoarthritis is a chronic, debilitating disease affecting hundreds of millions of people around the globe. There are no disease- modifying drugs or treatments available, except for knee arthroplasty. We conducted in vitro, in vivo, and animal studies on using multidomain single-domain antibodies (or we called it a megabody(™)) that targeted TNF-Alpha, IL-6, IL-1beta, NGF, MMP-13, ADAMST-4 and IKK- Alpha-Beta-forming a hepta-tropes as a potential DMOAD. To enhance the duration of the megabody(™) in the intraarticular, we engage a nanoparticle consist of PLGA (Poly-lacto- Gycolic-acid) with 75:25 percentage w/w, respectively.